Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes

NCT00104806 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped sponsor discontinues support

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DIETARY_SUPPLEMENT: cholecalciferol
DRUG: arsenic trioxide

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]